GLP1 drugs received initial regulatory approval in 2014, and 2021 is typically recognized as the year of a surge in use
Nobody wants to diet, but then, of course, nobody wants to obsess over their weight, or be judged for the way they look, or live in shame, or feel constantly scrutinised for the shape of their body we have been bred to do so, in part so that we can be sold quick-fix solutions like this
Sharing pens with others , even with a new needle, risks cross-infection and should never be done
Introduction If youre one of the millions of people with type 2 diabetes, youre probably always on the lookout for effective treatment options to manage your condition
Stay Informed and Supported with Healthon It can be hard to figure out the costs and access to semaglutide, but there is help if you need it